S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY

BACKGROUND: Evidences for antipsychotic augmentation for schizophrenic patients with sub-optimal efficacy have been lacking although it has been widespread therapeutic strategy in clinical practice. The purpose of this study was to investigate the efficacy and tolerability of blonanserin augmentatio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Schizophr Bull
Päätekijät: Bahk, Won-Myong, Kwon, Young Joon, Yoon, Bo-Hyun, Lee, Sang-Yeol, Lee, Kwanghun, Jon, Duk-In, Kim, Moon Doo, Lim, Eunsung
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887360/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby018.1007
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia